Abstract
A 60-year-old man with prostate adenocarcinoma status post radical prostatectomy and bilateral pelvic lymph node dissection referred for restaging 18F-fluciclovine PET/CT due to rising serum prostate-specific antigen levels (1.1 ng/mL at that time of imaging). PET/CT images were obtained from the proximal thighs to the vertex of the skull approximately 3 to 5 minutes after the IV administration of 347.8 MBq (9.4 mCi) of 18F-fluciclovine. PET/CT imaging demonstrated a focus of abnormally increased 18F-fluciclovine uptake at the right ureterovesical junction. Subsequent MRI of the pelvis revealed that this focus corresponded to a benign ureterocele.
Original language | English (US) |
---|---|
Pages (from-to) | E3-E5 |
Journal | Clinical nuclear medicine |
Volume | 46 |
Issue number | 1 |
DOIs | |
State | Published - 2021 |
Keywords
- F-fluciclovine
- PET/CT
- false-positive
- pitfalls
- ureterocele
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging